Scarica l'app Stockscreener
424.26
0.37%
-1.56
Dopo l'orario di chiusura:
424.26
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$425.82
Aprire:
$426.23
Volume 24 ore:
151.49K
Relative Volume:
0.59
Capitalizzazione di mercato:
$5.63B
Reddito:
$2.54B
Utile/perdita netta:
$259.78M
Rapporto P/E:
23.12
EPS:
18.3497
Flusso di cassa netto:
$377.12M
1 W Prestazione:
+0.50%
1M Prestazione:
+7.34%
6M Prestazione:
-2.38%
1 anno Prestazione:
-25.44%
Intervallo 1D:
$418.19
$426.23
Intervallo di 1 settimana:
$418.19
$432.13
Portata 52W:
$365.20
$583.96
Chemed Corp Stock (CHE) Company Profile
Nome
Chemed Corp
Settore
Industria
Telefono
(513)762-6690
Indirizzo
SUITE 2600, CINCINNATI, OH
Compare CHE vs HCA, THC, DVA, FMS, EHC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CHE
Chemed Corp
|
424.26 | 5.63B | 2.54B | 259.78M | 377.12M | 18.35 |
HCA
Hca Healthcare Inc
|
435.19 | 96.54B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
190.38 | 16.40B | 21.46B | 2.65B | 3.35B | 19.23 |
DVA
Davita Inc
|
198.65 | 12.75B | 13.64B | 1.05B | 1.31B | 9.555 |
FMS
Fresenius Medical Care Ag Adr
|
22.03 | 11.83B | 22.18B | 1.36B | 2.00B | 1.9216 |
EHC
Encompass Health Corp
|
106.10 | 10.53B | 6.07B | 793.80M | 464.40M | 5.9914 |
Chemed Corp Stock (CHE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-27 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2026-01-22 | Downgrade | Jefferies | Buy → Hold |
| 2025-09-02 | Aggiornamento | Jefferies | Hold → Buy |
| 2025-07-25 | Iniziato | Jefferies | Hold |
| 2020-03-11 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2019-11-01 | Aggiornamento | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-09-06 | Reiterato | BofA/Merrill | Buy |
| 2018-10-12 | Iniziato | BofA/Merrill | Buy |
| 2017-08-28 | Iniziato | KeyBanc Capital Mkts | Sector Weight |
| 2016-11-01 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2016-07-27 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2016-05-02 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2015-10-26 | Reiterato | Oppenheimer | Outperform |
| 2015-10-26 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2015-09-22 | Reiterato | Oppenheimer | Outperform |
| 2015-07-27 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2015-02-19 | Reiterato | Oppenheimer | Outperform |
| 2014-09-23 | Reiterato | Oppenheimer | Outperform |
| 2014-06-10 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2014-05-01 | Reiterato | Oppenheimer | Outperform |
| 2013-09-10 | Reiterato | Deutsche Bank | Hold |
| 2011-03-04 | Reiterato | Barclays Capital | Underweight |
| 2011-02-17 | Reiterato | Oppenheimer | Outperform |
| 2011-02-17 | Reiterato | RBC Capital Mkts | Sector Perform |
Mostra tutto
Chemed Corp Borsa (CHE) Ultime notizie
CHE SEC FilingsChemed Corp 10-K, 10-Q, 8-K Forms - Stock Titan
[144] CHEMED CORP SEC Filing - Stock Titan
Chemed director Patrick P. Grace sells $25,546 in stock By Investing.com - Investing.com Australia
Chemed director Patrick P. Grace sells $25,546 in stock - Investing.com
Chemed Corp (CHE) director sells 60 shares at $425.78 - Stock Titan
Chemed Corp stock (US1638321034): Home health and hospice growth continues to drive earnings - AD HOC NEWS
Chemed Corporation $CHE Shares Acquired by UBS Group AG - MarketBeat
CHE Technical Analysis | Trend, Signals & Chart Patterns | CHEMED CORP (NYSE:CHE) - ChartMill
Sadness This Mother's Day? VITAS® Healthcare Launches Free, Nationwide Mother's Day Grief Helpline - Quantisnow
The company behind VITAS and Roto-Rooter presents in Las Vegas May 12 - Stock Titan
Van Berkom & Associates Inc. Acquires 4,056 Shares of Chemed Corporation $CHE - MarketBeat
Chemed Corporation $CHE Shares Acquired by Mitsubishi UFJ Trust & Banking Corp - MarketBeat
Chemed CEO Kevin McNamara sells $842,260 in Che stock By Investing.com - Investing.com Australia
Chemed CEO Kevin McNamara sells $842,260 in Che stock - Investing.com
Chemed (CHE) CEO Kevin McNamara sells 2,000 shares at $421.13 average - Stock Titan
Chemed Corp (CHE) Stock Analysis: Navigating Healthcare Growth with a 5.77% Upside Potential - DirectorsTalk Interviews
Chemed (NYSE:CHE) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Chemed Corporation (NYSE: CHE) affiliate files Form 144 to sell 1,000 shares - Stock Titan
Kevin McNamara reports Common stock sales (CHE) on Form 144 - Stock Titan
Water Management Takes Centre Stage at Data Centre LIVE - GlobeNewswire Inc.
Vanguard Capital Management (CHE) reports 744,055 shares, 5.40% stake - Stock Titan
Vanguard holds 817,550 Chemed shares (CHE) — 5.93% stake - Stock Titan
(CHE) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Chemed (NYSE:CHE) Raised to Hold at Zacks Research - MarketBeat
CHE Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Chemed (NYSE: CHE) posts Q1 2026 revenue growth with lower profit - Stock Titan
Chemed Q1 Earnings Call Highlights - MarketBeat
CHE Stock Up Following Q1 Earnings & Revenue Beat, Margins Down - Yahoo Finance
RBC Capital raises Chemed stock price target on strong results By Investing.com - Investing.com Nigeria
Chemed Corp (CHE) Stock Analysis: Investor Outlook On Healthcare's Resilient Performer - DirectorsTalk Interviews
RBC Capital raises Chemed stock price target on strong results - Investing.com
VITAS posts strong earnings, revenue growth in 2026 Q1 - McKnights Home Care
Ave Maria Growth Fund's Chemed Corp(CHE) Holding History - GuruFocus
Abacus FCF Advisors LLC Acquires New Holdings in Chemed Corporation $CHE - MarketBeat
Sensient Technologies, Chemed, AMD, Arm and other big stocks moving higher on Friday - MSN
Why Chemed (CHE) Stock Is Up Today - Yahoo Finance
CHE Q1 Deep Dive: VITAS Drives Growth, Roto-Rooter Adapts to Higher Marketing Costs - Yahoo Finance
Impax Asset Management Group plc Trims Position in Chemed Corporation $CHE - MarketBeat
Chemed Corporation (NYSE:CHE) Q1 2026 Earnings Call Transcript - Insider Monkey
Chemed Stock Jumps 11% on Q1 Beat, VITAS Hospice Strength and Raised 2026 Outlook - inkl
CHE: VITAS outperformed in Q1 2026, driving raised guidance, while Roto-Rooter navigated headwinds - TradingView
Full Transcript: Chemed Q1 2026 Earnings Call - Benzinga
Chemed (CHE) Q1 2026 Earnings Call Transcript - AOL.com
CHE: VITAS outperformed expectations and guidance was raised, while Roto-Rooter saw mixed results and higher costs - TradingView
Chemed Q1 2026 presentation reveals Roto-Rooter divestiture plans - Investing.com
Transcript : Chemed Corporation, Q1 2026 Earnings Call, Apr 24, 2026 - marketscreener.com
Earnings call transcript: Chemed Q1 2026 earnings exceed forecasts, stock surges - Investing.com India
Earnings call transcript: Chemed Q1 2026 earnings exceed forecasts, stock surges By Investing.com - Investing.com South Africa
Sensient Technologies, Chemed, AMD, Arm And Other Big Stocks Moving Higher On Friday - Benzinga
Chemed (NYSE:CHE) Shares Gap Up After Strong Earnings - MarketBeat
Chemed Corporation Q1 2026 Earnings Call Summary - Yahoo Finance
Chemed Corp Azioni (CHE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.12%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):